Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... [Yahoo! Finance]
Arcadia Biosciences, Inc. (RKDA)
Last arcadia biosciences, inc. earnings: 3/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arcadiabio.com
Company Research
Source: Yahoo! Finance
SG&A Expenses: Approximately $2.2 million, including $380,000 of transition costs related to the sale of GoodWheat, a 20% increase from last year. Cash Usage: Declined to $1.5 million, the lowest level since going public, including $430,000 related to discontinued operations. Cash and Short-term Investments: $6.6 million at the end of Q3, down from $8.1 million at the end of Q2. Inventory Balance: $835,000, a 15% decrease from the end of Q2. Cost of Revenues: Approximately $1 million, including a $150,000 write-down related to hemp and GoodWheat seed. Research and Development Costs: $24,000, an increase of $9,000 compared to Q3 of last year. Loss from Discontinued Operations: $430,000, a 77% decrease compared to the same period last year. Warning! GuruFocus has detected 6 Warning Signs with RKDA. Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Arcadia Biosciences Inc ( NASDAQ:RKDA
Show less
Read more
Impact Snapshot
Event Time:
RKDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RKDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RKDA alerts
High impacting Arcadia Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
RKDA
News
- Arcadia Biosciences, Inc. (NASDAQ: RKDA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- ARCADIA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Arcadia Biosciences, Inc. - RKDABusiness Wire
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, IPG, OMC, EBTC on Behalf of ShareholdersPR Newswire
- Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105% [Yahoo! Finance]Yahoo! Finance
- Arcadia Biosciences, Inc. (NASDAQ: RKDA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
RKDA
Earnings
- 11/12/24 - Miss
RKDA
Sec Filings
- 12/11/24 - Form 425
- 12/11/24 - Form 8-K
- 12/6/24 - Form 425
- RKDA's page on the SEC website